DiNuzzo Private Wealth’s Corcept Therapeutics CORT Stock Holding History

DiNuzzo Private Wealth’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87	Hold	1	–	–	﹤0.01%	1303
2026 Q1	$41	Sell	1 -16	-94%	-$598	﹤0.01%	1315
2025 Q4	$592	Hold	17	–	–	﹤0.01%	1031
2025 Q3	$1.19K	Hold	17	–	–	﹤0.01%	816
2025 Q2	$1.25K	Hold	17	–	–	﹤0.01%	790
2025 Q1	$1.94K	Hold	17	–	–	﹤0.01%	606
2024 Q4	$857	Sell	17 -1	-6%	-$52	﹤0.01%	898
2024 Q3	$834	Buy	18 +1	+6%	+$36	﹤0.01%	926
2024 Q2	$553	Buy	17 +1	+6%	+$27	﹤0.01%	1011
2024 Q1	$404	Sell	16 -1	-6%	-$24	﹤0.01%	1040
2023 Q4	$553	Buy	+17	New	+$467	﹤0.01%	940

Other funds holding CORT

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

DiNuzzo Private Wealth's CORT Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 1 share worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #1303.

DiNuzzo Private Wealth first reported a position in CORT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.94K in Q1 2025. 93 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

DiNuzzo Private Wealth held 1 share of Corcept Therapeutics worth $87 as of Q2 2026.
DiNuzzo Private Wealth left its Corcept Therapeutics share count unchanged in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1303 holding.
DiNuzzo Private Wealth first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 11 quarters since.
DiNuzzo Private Wealth's Corcept Therapeutics position peaked at $1.94K in Q1 2025.
93 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.